Cargando…
Die nosokomiale Pneumonie: State-of-the-Art
Nosocomial pneumonia is among the most frequent infections in the intensive care unit with high morbidity and mortality. The decisive factor for treatment failure is inadequate previous antibiotic treatment. Broad spectrum and sufficiently high dosed initial treatment is crucial. To prevent further...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Steinkopff-Verlag
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101873/ https://www.ncbi.nlm.nih.gov/pubmed/32287633 http://dx.doi.org/10.1007/s00390-006-0721-2 |
_version_ | 1783511712206422016 |
---|---|
author | Welte, T. |
author_facet | Welte, T. |
author_sort | Welte, T. |
collection | PubMed |
description | Nosocomial pneumonia is among the most frequent infections in the intensive care unit with high morbidity and mortality. The decisive factor for treatment failure is inadequate previous antibiotic treatment. Broad spectrum and sufficiently high dosed initial treatment is crucial. To prevent further resistances, the antibiotic treatment must be evaluated early. Depending on the treatment success, treatment has to be changed or terminated. Deescalation is possible and sensible after three days. A treatment period of seven days should not routinely be exceeded. The treatment recommendations should be adapted to local resistances and the local statistics of frequent pathogens. A further factor for treatment decision-making is the risk analysis of the patient (previous treatment, stays in hospitals or nursing homes, concomitant diseases). |
format | Online Article Text |
id | pubmed-7101873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Steinkopff-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-71018732020-03-31 Die nosokomiale Pneumonie: State-of-the-Art Welte, T. Intensivmed Notfallmed Beitrag Zum Themenschwerpunkt Nosocomial pneumonia is among the most frequent infections in the intensive care unit with high morbidity and mortality. The decisive factor for treatment failure is inadequate previous antibiotic treatment. Broad spectrum and sufficiently high dosed initial treatment is crucial. To prevent further resistances, the antibiotic treatment must be evaluated early. Depending on the treatment success, treatment has to be changed or terminated. Deescalation is possible and sensible after three days. A treatment period of seven days should not routinely be exceeded. The treatment recommendations should be adapted to local resistances and the local statistics of frequent pathogens. A further factor for treatment decision-making is the risk analysis of the patient (previous treatment, stays in hospitals or nursing homes, concomitant diseases). Steinkopff-Verlag 2006 /pmc/articles/PMC7101873/ /pubmed/32287633 http://dx.doi.org/10.1007/s00390-006-0721-2 Text en © Steinkopff-Verlag 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Beitrag Zum Themenschwerpunkt Welte, T. Die nosokomiale Pneumonie: State-of-the-Art |
title | Die nosokomiale Pneumonie: State-of-the-Art |
title_full | Die nosokomiale Pneumonie: State-of-the-Art |
title_fullStr | Die nosokomiale Pneumonie: State-of-the-Art |
title_full_unstemmed | Die nosokomiale Pneumonie: State-of-the-Art |
title_short | Die nosokomiale Pneumonie: State-of-the-Art |
title_sort | die nosokomiale pneumonie: state-of-the-art |
topic | Beitrag Zum Themenschwerpunkt |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101873/ https://www.ncbi.nlm.nih.gov/pubmed/32287633 http://dx.doi.org/10.1007/s00390-006-0721-2 |
work_keys_str_mv | AT weltet dienosokomialepneumoniestateoftheart |